Organon & Co. (NYSE: OGN)
Organon & Co. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Organon & Co. Company Info
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
News & Analysis
Organon (OGN) Fiscal Q2 Revenue Beats 1%
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
High-yielding stocks may be tantalizing, but they often come with risks.
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
These stocks can significantly bolster your income.
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.
Why Shares of Organon Fell 15% Thursday
The company reported fourth-quarter and year-end financials.
3 of the Best Value Stocks to Buy Heading Into April
With these shares at modest valuations, you can score some cheap long-term investments.
Should Investors Hold Out Hope for bluebird bio and Merck Spinoff Organon?
Neither healthcare stock has performed well so far this year.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.